Alpha 2.0
Login Register
» Authors » Nipaporn Siripon

Nipaporn Siripon

Explore the profile of Nipaporn Siripon including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 125
Followers 0
Related Specialties
General Medicine
Science
Gastroenterology
Top 10 Co-Authors
Yong Poovorawan
Kessarin Thanapirom
Piyawat Komolmit
Supachaya Sriphoosanaphan
Rujipat Wasitthankasem
Pisit Tangkijvanich
Panarat Thaimai
Prooksa Ananchuensook
Chompoonut Auphimai
Preeyaporn Vichaiwattana
Published In
PLoS One
BMC Gastroenterol
PeerJ
Vaccines (Basel)
Sci Rep
Affiliations
Soon will be listed here.
Recent Articles
1.
Bacterial DNA Translocation Is Associated With Overt Hepatic Encephalopathy and Mortality in Patients With Cirrhosis
Thanapirom K, Suksawatamnuay S, Wejnaruemarn S, Thaimai P, Siripon N, Ananchuensook P, et al.
Clin Transl Gastroenterol . 2024 Mar; 15(5):e00697. PMID: 38488171
Introduction: Data on the relationship between bacterial translocation, hepatic encephalopathy (HE), and mortality are scarce. This study aimed to assess the association between bacterial DNA (bactDNA) translocation, inflammatory response, ammonia...
2.
Prevalence of hepatitis D virus infection among patients with chronic hepatitis B infection in a tertiary care centre in Thailand
Ananchuensook P, Suksawatamnuay S, Thaimai P, Siripon N, Sriphoosanaphan S, Thanapirom K, et al.
Sci Rep . 2023 Dec; 13(1):22633. PMID: 38114689
Knowledge about the epidemiology of hepatitis D virus (HDV) is essential for effective screening and management. Our study aimed to update the prevalence of HDV infection among patients with hepatitis...
3.
Immunogenicity, Immune Dynamics, and Subsequent Response to the Booster Dose of Heterologous versus Homologous Prime-Boost Regimens with Adenoviral Vector and mRNA SARS-CoV-2 Vaccine among Liver Transplant Recipients: A Prospective Study
Sriphoosanaphan S, Suksawatamnuay S, Srisoonthorn N, Siripon N, Thaimai P, Ananchuensook P, et al.
Vaccines (Basel) . 2022 Dec; 10(12). PMID: 36560535
Background: Heterologous prime-boost vaccination potentially augments the immune response against SARS-CoV-2 in liver transplant (LT) recipients. We investigated immunogenicity induced by different primary prime-boost vaccination protocols and the subsequent response...
4.
Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization
Ananchuensook P, Sriphoosanaphan S, Suksawatamnauy S, Siripon N, Pinjaroen N, Geratikornsupuk N, et al.
BMC Gastroenterol . 2022 Jun; 22(1):295. PMID: 35701739
Background: Heterogeneity of liver function and tumor burden in intermediate-stage hepatocellular carcinoma (HCC) results in different outcomes after transarterial chemoembolization (TACE). Easy albumin-bilirubin (EZ-ALBI), a simplified albumin-bilirubin (ALBI) score, has...
5.
Stability of hepatitis B virus pregenomic RNA in plasma specimens under various temperatures and storage conditions
Rattanachaisit P, Suksawatamnuay S, Sriphoosanaphan S, Thanapirom K, Thaimai P, Siripon N, et al.
PeerJ . 2021 May; 9:e11207. PMID: 33954043
Background: Hepatitis B virus (HBV) pregenomic RNA (pgRNA) has gained increasing attention owing to its role in replication of covalently closed circular DNA (cccDNA) in HBV. This marker has the...
6.
Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policy
Wasitthankasem R, Vichaiwattana P, Siripon N, Posuwan N, Auphimai C, Klinfueng S, et al.
PLoS One . 2018 Aug; 13(8):e0202991. PMID: 30138441
The World Health Organization aims to eliminate HCV infection worldwide by 2030. A targeted HCV screening policy is currently unavailable in Thailand, but a decrease in HCV infection has been...
7.
Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study
Wasitthankasem R, Vichaiwattana P, Siripon N, Posuwan N, Auphimai C, Klinfueng S, et al.
PLoS One . 2018 Apr; 13(4):e0196301. PMID: 29689073
The prevalence of hepatitis C virus (HCV) infection has been decreasing globally, but the growing effects of HCV-related morbidity and mortality remain of concern. Advances in curative medicine, involving direct-acting...
8.
HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs
Wasitthankasem R, Vichaiwattana P, Auphimai C, Siripon N, Klinfueng S, Tangkijvanich P, et al.
PeerJ . 2017 Nov; 5:e4008. PMID: 29134150
The core antigen of the hepatitis C virus (HCV Ag) presents an alternative marker to HCV RNA when screening patients for HCV viremia. This study sought to evaluate the utility...
9.
Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence
Wasitthankasem R, Vichaiwattana P, Siripon N, Posuwan N, Auphimai C, Klinfueng S, et al.
PLoS One . 2017 May; 12(5):e0177022. PMID: 28475637
Improved awareness of the hepatitis C virus (HCV) transmission has contributed to the overall decline in the HCV infection rate in some developing countries including Thailand. Chronic HCV infection in...
10.
Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia
Wasitthankasem R, Vongpunsawad S, Siripon N, Suya C, Chulothok P, Chaiear K, et al.
PLoS One . 2015 May; 10(5):e0126764. PMID: 25962112
The majority of hepatitis C virus (HCV) infection results in chronic infection, which can lead to liver cirrhosis and hepatocellular carcinoma. Global burden of hepatitis C virus (HCV) is estimated...